Invention Grant
- Patent Title: Cyclic di-nucleotide compounds as STING agonists
-
Application No.: US15886568Application Date: 2018-02-01
-
Publication No.: US10759825B2Publication Date: 2020-09-01
- Inventor: Michael D. Altman , Brian Andresen , Wonsuk Chang , Matthew Lloyd Childers , Jared N. Cumming , James P. Jewell , Jongwon Lim , Alan B. Northrup , Ryan D. Otte , Benjamin Wesley Trotter , Quang T. Truong , Shawn P. Walsh , Kake Zhao
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Julie M. Lake; Catherine D. Fitch
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; C07H21/04 ; C07H21/02 ; A61K39/39 ; C07H19/20 ; C07H19/23 ; C07H21/00 ; A61P35/00 ; A61K31/7064 ; A61K31/7084 ; A61K31/708 ; A61K31/706 ; A61K31/7076
Abstract:
A class of polycyclic compounds of general formula (I), of general formula (I′), or of general formula (I″), wherein Base1, Base2, Y, Ya, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3, R4, R4a, R5, R6, R6a, R7, R7a, R8, and R8a are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.
Public/Granted literature
- US20180244712A1 CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS Public/Granted day:2018-08-30
Information query
IPC分类:
